vs
Gaming & Leisure Properties, Inc.（GLPI）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
Gaming & Leisure Properties, Inc.的季度营收约是Bio-Techne的1.3倍（$420.0M vs $311.4M），Gaming & Leisure Properties, Inc.净利率更高（57.0% vs 16.4%，领先40.6%），Gaming & Leisure Properties, Inc.同比增速更快（6.3% vs -1.5%），过去两年Gaming & Leisure Properties, Inc.的营收复合增速更高（5.0% vs 1.3%）
博彩与休闲地产公司（GLPI）是一家专注于赌场物业的房地产投资信托（REIT），总部位于宾夕法尼亚州怀奥米辛。公司于2013年11月从宾州国民娱乐分拆成立，目前持有62处赌场物业，全部对外出租给其他企业运营。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
GLPI vs TECH — 直观对比
营收规模更大
GLPI
是对方的1.3倍
$311.4M
营收增速更快
GLPI
高出7.8%
-1.5%
净利率更高
GLPI
高出40.6%
16.4%
两年增速更快
GLPI
近两年复合增速
1.3%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $420.0M | $311.4M |
| 净利润 | $239.4M | $51.0M |
| 毛利率 | — | 66.9% |
| 营业利润率 | 79.4% | 24.2% |
| 净利率 | 57.0% | 16.4% |
| 营收同比 | 6.3% | -1.5% |
| 净利润同比 | 40.5% | 126.0% |
| 每股收益（稀释后） | — | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GLPITECH
| Q1 26 | $420.0M | $311.4M | ||
| Q4 25 | $407.0M | $295.9M | ||
| Q3 25 | $397.6M | — | ||
| Q2 25 | $394.9M | $317.0M | ||
| Q1 25 | $395.2M | $316.2M | ||
| Q4 24 | $389.6M | $297.0M | ||
| Q3 24 | $385.3M | $289.5M | ||
| Q2 24 | $380.6M | $306.1M |
净利润GLPITECH
| Q1 26 | $239.4M | $51.0M | ||
| Q4 25 | $275.4M | $38.0M | ||
| Q3 25 | $241.2M | — | ||
| Q2 25 | $151.4M | $-17.7M | ||
| Q1 25 | $165.2M | $22.6M | ||
| Q4 24 | $223.6M | $34.9M | ||
| Q3 24 | $184.7M | $33.6M | ||
| Q2 24 | $208.3M | $40.6M |
毛利率GLPITECH
| Q1 26 | — | 66.9% | ||
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% |
营业利润率GLPITECH
| Q1 26 | 79.4% | 24.2% | ||
| Q4 25 | 89.3% | 18.4% | ||
| Q3 25 | 84.8% | — | ||
| Q2 25 | 61.3% | -7.5% | ||
| Q1 25 | 65.5% | 12.2% | ||
| Q4 24 | 79.1% | 16.0% | ||
| Q3 24 | 70.4% | 13.8% | ||
| Q2 24 | 77.1% | 15.0% |
净利率GLPITECH
| Q1 26 | 57.0% | 16.4% | ||
| Q4 25 | 67.6% | 12.8% | ||
| Q3 25 | 60.7% | — | ||
| Q2 25 | 38.4% | -5.6% | ||
| Q1 25 | 41.8% | 7.1% | ||
| Q4 24 | 57.4% | 11.7% | ||
| Q3 24 | 47.9% | 11.6% | ||
| Q2 24 | 54.7% | 13.3% |
每股收益（稀释后）GLPITECH
| Q1 26 | — | $0.32 | ||
| Q4 25 | $0.96 | $0.24 | ||
| Q3 25 | $0.85 | — | ||
| Q2 25 | $0.54 | $-0.11 | ||
| Q1 25 | $0.60 | $0.14 | ||
| Q4 24 | $0.79 | $0.22 | ||
| Q3 24 | $0.67 | $0.21 | ||
| Q2 24 | $0.77 | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $274.5M | $209.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.0B | $2.1B |
| 总资产 | $13.8B | $2.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GLPITECH
| Q1 26 | $274.5M | $209.8M | ||
| Q4 25 | — | $172.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $162.2M | ||
| Q1 25 | — | $140.7M | ||
| Q4 24 | $560.8M | $177.5M | ||
| Q3 24 | $560.8M | $187.5M | ||
| Q2 24 | $560.8M | $152.9M |
总债务GLPITECH
| Q1 26 | — | — | ||
| Q4 25 | $7.2B | $260.0M | ||
| Q3 25 | $7.2B | — | ||
| Q2 25 | $6.9B | $346.0M | ||
| Q1 25 | $6.9B | $330.0M | ||
| Q4 24 | $7.7B | $300.0M | ||
| Q3 24 | $7.4B | $300.0M | ||
| Q2 24 | $6.6B | $319.0M |
股东权益GLPITECH
| Q1 26 | $5.0B | $2.1B | ||
| Q4 25 | $4.6B | $2.0B | ||
| Q3 25 | $4.6B | — | ||
| Q2 25 | $4.6B | $1.9B | ||
| Q1 25 | $4.2B | $2.0B | ||
| Q4 24 | $4.3B | $2.1B | ||
| Q3 24 | $4.3B | $2.1B | ||
| Q2 24 | $4.1B | $2.1B |
总资产GLPITECH
| Q1 26 | $13.8B | $2.6B | ||
| Q4 25 | $12.9B | $2.5B | ||
| Q3 25 | $12.8B | — | ||
| Q2 25 | $12.5B | $2.6B | ||
| Q1 25 | $12.1B | $2.6B | ||
| Q4 24 | $13.1B | $2.7B | ||
| Q3 24 | $12.7B | $2.7B | ||
| Q2 24 | $11.8B | $2.7B |
负债/权益比GLPITECH
| Q1 26 | — | — | ||
| Q4 25 | 1.56× | 0.13× | ||
| Q3 25 | 1.57× | — | ||
| Q2 25 | 1.51× | 0.18× | ||
| Q1 25 | 1.63× | 0.16× | ||
| Q4 24 | 1.81× | 0.14× | ||
| Q3 24 | 1.74× | 0.14× | ||
| Q2 24 | 1.60× | 0.15× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GLPI
暂无分部数据
TECH
| Protein Sciences segment revenue | $226.2M | 73% |
| Diagnostics and Spatial Biology segment revenue | $85.6M | 27% |
| Other revenue (1) | $5.4M | 2% |
